Skip to main content
Continuing Medical Education

Continuing Medical Education

FACULTY - War on Pain Updated

COURSE CHAIRS AND CONTENT REVIEWERS

Scott M. Fishman, M.D.
Professor and Chief of the Division of Pain Medicine,
Department of Anesthesiology and Pain Medicine
University of California, Davis, School of Medicine

Paul G. Kreis, M.D.
Medical Director of the UC Davis Pain Management Clinic,
Associate Professor, Division of Pain Medicine,
Department of Anesthesiology and Pain Medicine
University of California, Davis, School of Medicine

Gagan Mahajan, M.D.
Director of Fellowship in Pain Medicine,
Assistant Professor, Division of Pain Medicine,
Department of Anesthesiology and Pain Medicine
University of California, Davis, School of Medicine

DEPARTMENT OF ANESTHESIOLOGY AND PAIN MEDICINE FACULTY

Kenneth T. Furukawa, M.D.
Associate Clinical Professor
Department of Anesthesiology and Pain Medicine
University of California, Davis, School of Medicine

Ingela C. Symreng, Psy.D.
Director, Pain Psychology
Assistant Clinical Professor, Department of
Anesthesiology and Pain Medicine
University of California, Davis, School of Medicine

Ben A. Rich, JD, Ph.D.
Associate Professor of Bioethics
The Bioethics Program of the University of California, Davis

DEPARTMENT OF INTERNAL MEDICINE FACULTY

John F. MacMillan Jr., M.D.
Assistant Clinical Professor
Division of Pulmonary and Care Medicine,
Section of Hospital Medicine
Department of Internal Medicine,
University of California, Davis, School of Medicine

FAMILY PRACTICE

Jeffrey A. Applebaum, MD, FAAFP
Assistant Clinical Professor of Family Practice
UC Davis Medical Center
Primary Care Medicine and Primary Care Psychiatry
Master Clinician’s Certification in Psychopharmacology
from Neuroscience Education Institute, University of California, San Diego

Faculty Disclosure

 Disclosure of Relevant Financial Relationships: As a provider accredited by the Accreditation Council for Continuing Medical Education, the University of California, Davis, Health System Office of Continuing Medical Education must ensure balance, independence and objectivity in all CME activities to promote improvements in health care and not proprietary interests of a commercial interest. The provider controls all decisions related to identification of CME needs, determination of educational objectives, selection and presentation of content, selection of all persons and organizations that will be in a position to control the content, selection of educational methods and evaluation of the activity. Course directors, planning committee members, presenters, authors, moderators, panel members and others in a position to control the content of this activity are required to disclose relevant financial relationships with commercial interests related to the subject matter of this educational activity. Learners are able to assess the potential for commercial bias in information when complete disclosure, resolution of conflicts of interest, and acknowledgment of commercial support are provided prior to the activity. Informed learners are the final safeguards in assuring that a CME activity is independent from commercial support. We believe this mechanism contributes to the transparency and accountability of CME.

The following have indicated financial interest or affiliation:

 Speaker name  Nature of Relationship - Commercial Interest
Jeffrey A. Applebaum, MD, FAAFP Speakers’ Bureau - Forest Laboratories and Astra Zeneca
Paul G. Kreis, MD Speakers’ Bureau - Pfizer/King Pharm/Advanced Bionics
Trainer for Cadaver Labs Boston Scientific

They will support their lecture and clinical recommendations with the “best available evidence” from the medical literature.

The following have indicated no financial interest/affiliation that may affect presentations

Scott M. Fishman, M.D.  John F. MacMillan Jr., M.D
Kenneth T. Furukawa, M.D. Ben A. Rich, JD, PhD
Gagan Mahajan, M.D.  Ingela C. Symreng, PsyD 

Bibliography of supporting material for course conent

•  Responsible Opioid Prescribing: A Physician's Guide
by Scott M. Fishman, M.D.
published 2009 The University of Wisconsin Board of Regints
• Essential Psychopharmacology,  3rd Edition
by Stephen Stahl, M.D., Ph.D.
published 2008 Cambridge University Press
• Substance Abuse and Mental Health Services Administration. (2010). Results from the 2009 National Survey on Drug Use and Health: National Findings (Office of Applied Studies, NSDUH Series H-36, HHS Publication No. SMA 09-4434). Rockville, MD.
• National Drug Control Strategy Data Supplement 2010
http://www.whitehousedrugpolicy.gov/publications/policy/ndcs10/ndcs10_data_supl/10datasupplement.pdf
• National Drug Control Strategy 2010 Annual Report
http://www.whitehousedrugpolicy.gov/publications/policy/ndcs10/index.html
• California Assembly Bill AB487
http://www.leginfo.ca.gov/cgi-bin/displaycode?section=bpc&group=02001-03000&file=2190-2196.5
• Cole AJ and Herring SA: Eds. The Low Back Pain Handbook. 1997.
• Deyo, RA, Rainvelle, J, Kent, DL. What can the history and physical examination tell us about low back pain? JAMA 1992; 268:760.
• Kirkaldy-Willis WH and Bernard TH: Eds. Managing Low Back Pain. 1999.
• Reider B. The Orthopaedic Physical Examination. 1999.
• Rucker KS, Cole AJ and Weinstein SM: Eds. Low Back Pain: A Symptom-Based Approach to Diagnosis and Treatment. 2001.
• Beaton LE, Anson BJ. The sciatic nerve and the piriformis muscle. J Bone Joint Surg.1938;20:686-88
• Sweezy, RL: Ed. Physical Medicine and Rehabilitation Clinics of North America. 1998
• Hoppenfeld S. Physical Examination of the Spine and Extremities. 1976
• Jensen MC et al. MRI of the lumbar spine in people without back pain. NEJM 1994;331(2):69-73.
• Srejic U, Calvillo O, Kabakibou K. Viscosupplementation: a new concept in the treatment of sacroiliac joint syndrome: a preliminary report of four cases.Reg Anesth Pain Med. 1999 Jan-Feb;24(1):84-88